Compounds > acifran
Page last updated: 2024-08-23

acifran and Hyperlipoproteinemia Type II

acifran has been researched along with Hyperlipoproteinemia Type II in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeBovis, MR; Edwards, KD; LaRosa, JC; Miller, VT; Stoy, DB1
Edwards, KD; Hunninghake, DB; Sopko, GS; Tosiello, RL1

Trials

2 trial(s) available for acifran and Hyperlipoproteinemia Type II

ArticleYear
Acifran: a double-blind, randomized, placebo-controlled efficacy study in type IIa hyperlipoproteinemic patients.
    Artery, 1987, Volume: 14, Issue:6

    Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Double-Blind Method; Female; Furans; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Triglycerides

1987
Controlled trial of acifran in type II hyperlipoproteinemia.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:3

    Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Furans; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Random Allocation; Triglycerides

1985